RIGANTI, Chiara

RIGANTI, Chiara  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 310 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autore(i) File
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers 2020 Braconi L.; Bartolucci G.; Contino M.; Chiaramonte N.; Giampietro R.; Manetti D.; Perrone M.G.; Romanelli M.N.; Colabufo N.A.; Riganti C.; Dei S.; Teodori E.
ABCA1, apoA-I, and BTN3A1: A Legitimate ménage à trois in dendritic cells 2018 Riganti, Chiara; Castella, Barbara; Massaia, Massimo
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma 2020 Belisario, Dimas Carolina; Akman, Muhlis; Godel, Martina; Campani, Virginia; Patrizio, Maria Pia; Scotti, Lorena; Hattinger, Claudia Maria; De Rosa, Giuseppe De; Donadelli, Massimo; Serra, Massimo; Kopecka, Joanna; Riganti, Chiara
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells 2019 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 2015 Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells 2011 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations 2018 Magliocca, Salvatore; De Caro, Carmen; Lazzarato, Loretta; Russo, Roberto; Rolando, Barbara; Chegaev, Konstantin; Marini, Elisabetta; Nieddu, Maria; Burrai, Lucia; Boatto, Gianpiero; Cristiano, Claudia; Marabello, Domenica; Gazzano, Elena; Riganti, Chiara; Sodano, Federica; Rimoli, Maria Grazia
Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells 2008 Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 2017 Principe, Moitza; Borgoni, Simone; Cascione, Mariafrancesca; Chattaragada, Michelle Samuel; Ferri-Borgogno, Sammy; Capello, Michela; Bulfamante, Sara; Chapelle, Jennifer; Di Modugno, Francesca; Defilippi, Paola; Nisticò, Paola; Cappello, Paola; Riganti, Chiara; Leporatti, Stefano; Novelli, Francesco
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma 2015 Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M.
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 2019 Villanova, Tania; Gesmundo, Iacopo; Audrito, Valentina; Vitale, Nicoletta; Silvagno, Francesca; Musuraca, Chiara; Righi, Luisella; Libener, Roberta; Riganti, Chiara; Bironzo, Paolo; Deaglio, Silvia; Papotti, Mauro; Cai, Renzhi; Sha, Wei; Ghigo, Ezio; Schally, Andrew V; Granata, Riccarda
Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells 2011 E. Gazzano; E. Aldieri; C. Riganti; F. Silvagno; S. Orecchia; P.G. Betta; S. Doublier; M. Polimeni; A. Bosia; D. Ghigo
Antioxidants Prevent the RhoA Inhibition Evoked by Crocidolite Asbestos in Human Mesothelial and Mesothelioma Cells. 2011 Aldieri E; Riganti C; Silvagno F; Orecchia S; Betta PG; Doublier S; Gazzano E; Polimeni M; Bosia A; Ghigo D.
Applicability and limitations in the characterization of poly-dispersed engineered nanomaterials in cell media by dinamic light scattering (DLS) 2019 Arianna Marucco, Elisabetta Aldieri, Riccardo Leinardi, Enrico Bergamaschi, Chiara Riganti, Ivana Fenoglio
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression 2009 Riganti C; Doublier S; Viarisio D; Miraglia E; Pescarmona G; Ghigo D; Bosia A
Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation 2003 ALDIERI E.; ATRAGENE D.; BERGANDI L.; RIGANTI C.; COSTAMAGNA C.; A. BOSIA; GHIGO D.
Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha 2008 Riganti C; Doublier S; Aldieri E; Orecchia S; Betta PG; Gazzano E; Ghigo D; Bosia A
Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition 2007 RIGANTI C; ORECCHIA S; SILVAGNO F; PESCARMONA GP; BETTA PG; GAZZANO E; ALDIERI E; GHIGO D; BOSIA A
Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer. 2011 Riganti C; Pinto H; Bolli E; Belisario DC; Calogero RA; Bosia A; Cavallo F
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells 2017 Castella, Barbara; Kopecka, Joanna; Sciancalepore, Patrizia; Mandili, Giorgia; Foglietta, Myriam; Mitro, Nico; Caruso, Donatella; Novelli, Francesco; Riganti, Chiara; Massaia, Massimo